Although genetic alterations are an important part of the pathogenesis of AML, many of the mutant genes (such as DNMT3A, FLT3, CEBPA, NPM1, TET2, IDH1, IDH2 etc.)which have been identified in recent years have contributed a lot to it. This evidence concerns the gene DNMT3A and acute myeloid leukemia.